Product Information
FLUTICASONE-VILANTEROL 200-25 is a generic product labeled by Prasco Laboratories, priced at $3.9137 per EA under NDC 66993013697. Its NADAC has been published 216 times since Aug 17, 2022.
FDA first approved this application on May 10, 2013.
Strength
200; 25 ug/1; ug/1
Manufacturer
Prasco LaboratoriesNDC
66993013697
Classification
Generic
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE FUROATE; VILANTEROL TRIFENATATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204275FDA Approved
5/10/2013
On Market Since
5/23/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE-VILANTEROL 200-25 has been published 216 times since Aug 17, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9137 per EA |
|---|---|
| All-time high | $3.9137 (Sep 30, 2026) |
| All-time low | $3.5679 (Jul 17, 2024) |
| 52-week high | $3.9137 |
| 52-week low | $3.7638 |
| Median price | $3.7999 |
| Average price | $3.7868 |
| Largest weekly change | -6.6% (Apr 17, 2024) |
| Weeks tracked | 216 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone furoate and vilanterol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone furoate and vilanterol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE-VILANTEROL 200-25?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-VILANTEROL 200-25, manufactured by Prasco Laboratories, is $3.9137 per EA (NDC 66993013697), effective Sep 30, 2026.
How has the price of FLUTICASONE-VILANTEROL 200-25 changed over time?
Over the history we have for it, the NADAC for FLUTICASONE-VILANTEROL 200-25 has held within roughly two percent of its current level. It has been tracked across 216 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for FLUTICASONE-VILANTEROL 200-25?
Since Aug 17, 2022, the NADAC for FLUTICASONE-VILANTEROL 200-25 has ranged from a low of $3.5679 (Jul 17, 2024) to a high of $3.9137 (Sep 30, 2026), with a median of $3.7999 per EA.
Are there cheaper alternatives to FLUTICASONE-VILANTEROL 200-25?
No other NADAC-published product currently shares the active ingredient and strength of FLUTICASONE-VILANTEROL 200-25 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUTICASONE-VILANTEROL 200-25?
FLUTICASONE-VILANTEROL 200-25 (NDC 66993013697) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.